Algert Global’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
LCM
DFO
Algert Global's NUVB Position: Q2 2026 in Review
Algert Global increased its Nuvation Bio (NUVB) stake by 24% in Q2 2026, buying an estimated $2.13M and bringing the position to 2,277,358 shares worth $12.9M. The position accounts for 0.15% of the portfolio, ranked #199.
Algert Global first reported a position in NUVB in Q1 2022 and has held it in 17 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Algert Global held 2,277,358 shares of Nuvation Bio worth $12.9M as of Q2 2026.
- Algert Global bought 435,280 Nuvation Bio shares in Q2 2026, an estimated $2.13M.
- Nuvation Bio made up 0.15% of Algert Global's portfolio in Q2 2026, its #199 holding.
- Algert Global first reported a position in Nuvation Bio in Q1 2022 and has held it in 17 quarters since.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.